Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic review

Serfaty, 2008, Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis, Diabetes Metab, 34, 634, 10.1016/S1262-3636(08)74597-X Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, 64, 73, 10.1002/hep.28431 Angulo, 2015, Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease, Gastroenterology, 149, 389, 10.1053/j.gastro.2015.04.043 Ekstedt, 2015, Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up, Hepatology, 61, 1547, 10.1002/hep.27368 Fracanzani, 2016, Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up, Atherosclerosis, 246, 208, 10.1016/j.atherosclerosis.2016.01.016 Oni, 2013, A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?, Atherosclerosis, 230, 258, 10.1016/j.atherosclerosis.2013.07.052 Targher, 2006, Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease, Diabetes Care, 29, 1325, 10.2337/dc06-0135 Wong, 2011, Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease, Gut, 60, 1721, 10.1136/gut.2011.242016 Sinn, 2017, Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study, Gut, 66, 323, 10.1136/gutjnl-2016-311854 Salvi, 2010, Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study, J Hypertens, 28, 1699, 10.1097/HJH.0b013e32833a7de6 van Sloten, 2014, Local stiffness of the carotid and femoral artery is associated with incident cardiovascular events and all-cause mortality: the Hoorn study, J Am Coll Cardiol, 63, 1739, 10.1016/j.jacc.2013.12.041 Anstee, 2018, Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease, Nat Rev Gastroenterol Hepatol, 15, 425, 10.1038/s41575-018-0010-0 Fracanzani, 2016, Epicardial adipose tissue (EAT) thickness is associated with cardiovascular and liver damage in nonalcoholic fatty liver disease, PLoS One, 11, 10.1371/journal.pone.0162473 Petta, 2015, Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease, J Hepatol, 62, 928, 10.1016/j.jhep.2014.11.030 Airaghi, 2018, Subclinical cerebrovascular disease in NAFLD without overt risk factors for atherosclerosis, Atherosclerosis, 268, 27, 10.1016/j.atherosclerosis.2017.11.012 Pigoni, 2018, Acquired hepatocerebral degeneration (AHD): a peculiar neurological impairment in advanced chronic liver disease, Metab Brain Dis, 33, 347, 10.1007/s11011-017-0107-0 Targher, 2016, Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis, J Hepatol, 65, 589, 10.1016/j.jhep.2016.05.013 Marchesini, 2003, Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome, Hepatology, 37, 917, 10.1053/jhep.2003.50161 Ratziu, 2010, A position statement on NAFLD/NASH based on the EASL 2009 special conference, J Hepatol, 53, 372, 10.1016/j.jhep.2010.04.008 Petta, 2011, Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease, Aliment Pharmacol Ther, 34, 757, 10.1111/j.1365-2036.2011.04788.x Targher, 2006, Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease, Clin Endocrinol (Oxf), 64, 679, 10.1111/j.1365-2265.2006.02527.x Tripodi, 2014, Procoagulant imbalance in patients with non-alcoholic fatty liver disease, J Hepatol, 61, 148, 10.1016/j.jhep.2014.03.013 Wieckowska, 2008, Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis, Am J Gastroenterol, 103, 1372, 10.1111/j.1572-0241.2007.01774.x Dongiovanni, 2013, PNPLA3 I148M polymorphism and progressive liver disease, World J Gastroenterol, 19, 6969, 10.3748/wjg.v19.i41.6969 Lauridsen, 2018, Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals, Eur Heart J, 39, 385, 10.1093/eurheartj/ehx662 Petta, 2013, PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease, PLoS One, 8, 10.1371/journal.pone.0074089 Dongiovanni, 2015, Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease, Hepatology, 61, 506, 10.1002/hep.27490 Abdeldyem, 2017, Nonalcoholic fatty liver disease in patients with acute ischemic stroke is associated with more severe stroke and worse outcome, J Clin Lipidol, 11, 915, 10.1016/j.jacl.2017.04.115 Moshayedi, 2014, Association between non-alcoholic fatty liver disease and ischemic stroke, Iran J Neurol, 13, 144 Alexander, 2018, Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: the reasons for geographic and racial differences in stroke cohort, PLoS One, 13, 10.1371/journal.pone.0194153 Kim, 2017, Liver fibrosis assessed with transient elastography is an independent risk factor for ischemic stroke, Atherosclerosis, 260, 156, 10.1016/j.atherosclerosis.2017.02.005 Tziomalos, 2013, Association between nonalcoholic fatty liver disease and acute ischemic stroke severity and outcome, World J Hepatol, 5, 621, 10.4254/wjh.v5.i11.621 El Azeem, 2013, Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events, J Saudi Heart Assoc, 25, 239, 10.1016/j.jsha.2013.07.004 Hamaguchi, 2007, Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease, World J Gastroenterol, 13, 1579, 10.3748/wjg.v13.i10.1579 Kunutsor, 2017, Associations of the fatty liver and hepatic steatosis indices with risk of cardiovascular disease: interrelationship with age, Clin Chim Acta, 466, 54, 10.1016/j.cca.2017.01.008 Bonita, 1988, Modification of rankin scale: recovery of motor function after stroke, Stroke, 19, 4, 10.1161/01.STR.19.12.1497 Fracanzani, 2008, Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes, Hepatology, 48, 792, 10.1002/hep.22429 Li, 2018, Non-alcoholic fatty liver disease is associated with stroke severity and progression of brainstem infarctions, Eur J Neurol, 25, 10.1111/ene.13556 Hu, 2018, Increased risk of cerebrovascular accident related to non-alcoholic fatty liver disease: a meta-analysis, Oncotarget, 9, 2752, 10.18632/oncotarget.22755 Mahfood Haddad, 2017, Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: a systematic review and meta-analysis, Diabetes Metab Syndr, 11 Suppl 1, S209, 10.1016/j.dsx.2016.12.033 Seo, 2016, Nonalcoholic fatty liver disease is associated with cognitive function in adults, Neurology, 86, 1136, 10.1212/WNL.0000000000002498 Weinstein, 2018, Association of nonalcoholic fatty liver disease with lower brain volume in healthy middle-aged adults in the framingham study, JAMA Neurol, 75, 97, 10.1001/jamaneurol.2017.3229 Bladowska, 2013, Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study, J Hepatol, 59, 651, 10.1016/j.jhep.2013.05.008 Takahashi, 2017, Reduced brain activity in female patients with non-alcoholic fatty liver disease as measured by near-infrared spectroscopy, PLoS One, 12, 10.1371/journal.pone.0174169 Debette, 2010, Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study, Stroke, 41, 600, 10.1161/STROKEAHA.109.570044 Debette, 2010, The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis, BMJ, 341, 10.1136/bmj.c3666 Petta, 2016, The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease, Medicine (Baltimore), 95, 10.1097/MD.0000000000003446 Tuttolomondo, 2018, Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study, Cardiovasc Diabetol, 17, 28, 10.1186/s12933-018-0670-7 Fargion, 2014, Nonalcoholic fatty liver disease and vascular disease: state-of-the-art, World J Gastroenterol, 20, 13306, 10.3748/wjg.v20.i37.13306 Tiehuis, 2014, Metabolic syndrome, prediabetes, and brain abnormalities on mri in patients with manifest arterial disease: the SMART-MR study, Diabetes Care, 37, 2515, 10.2337/dc14-0154 Bizino, 2015, MR of multi-organ involvement in the metabolic syndrome, Magn Reson Imaging Clin N Am, 23, 41, 10.1016/j.mric.2014.09.010 Lee, 2012, The relationship between arterial stiffness and nonalcoholic fatty liver disease, Dig Dis Sci, 57, 196, 10.1007/s10620-011-1819-3 Targher, 2010, Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease, N Engl J Med, 363, 1341, 10.1056/NEJMra0912063 Hansson, 2005, Inflammation, atherosclerosis, and coronary artery disease, N Engl J Med, 352, 1685, 10.1056/NEJMra043430 Rajappa, 2015, Interplay between inflammation and Hemostasis in patients with coronary artery disease, Indian J Clin Biochem, 30, 281, 10.1007/s12291-014-0438-0 Mellinger, 2015, Hepatic steatosis and cardiovascular disease outcomes: an analysis of the Framingham Heart Study, J Hepatol, 63, 470, 10.1016/j.jhep.2015.02.045 McColl, 2009, Systemic infection, inflammation and acute ischemic stroke, Neuroscience, 158, 1049, 10.1016/j.neuroscience.2008.08.019 Ghareeb, 2011, Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction, Metab Brain Dis, 26, 253, 10.1007/s11011-011-9261-y Kim, 2016, Non-alcoholic fatty liver disease induces signs of Alzheimer’s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model, J Neuroinflammation, 13, 1, 10.1186/s12974-015-0467-5 Long, 2015, Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study, Arterioscler Thromb Vasc Biol, 35, 1284, 10.1161/ATVBAHA.114.305200 Jaruvongvanich, 2017, Increased arterial stiffness in nonalcoholic fatty liver disease: a systematic review and meta-analysis, Eur J Gastroenterol Hepatol, 29, e28, 10.1097/MEG.0000000000000909 Brisset, 2013, Large-vessel correlates of cerebral small-vessel disease, Neurology, 80, 662, 10.1212/WNL.0b013e318281ccc2 Selwaness, 2014, Arterial stiffness is associated with carotid intraplaque hemorrhage in the general population: the Rotterdam study, Arterioscler Thromb Vasc Biol, 34, 927, 10.1161/ATVBAHA.113.302603 Kim, 2009, Relationship between brachial-ankle pulse wave velocity and cognitive function in an elderly community-dwelling population with metabolic syndrome, Arch Gerontol Geriatr, 49, 176, 10.1016/j.archger.2008.07.004